These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18816747)

  • 21. Evaluation of surveillance programmes for colorectal cancer in ulcerative colitis patients by case-control studies: methodological considerations.
    Zack MM; Ekbom A; Persson PG; Adami HO
    J Med Screen; 1997; 4(3):137-41. PubMed ID: 9368870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Colorectal cancer and ulcerative colitis--which patients should be checked?].
    Moum B
    Tidsskr Nor Laegeforen; 2002 Nov; 122(27):2624-6. PubMed ID: 12523193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of endoscopy in follow-up of Crohn disease and ulcerative colitis].
    Schölmerich J
    Bildgebung; 1993 Apr; 60 Suppl 1():33-7. PubMed ID: 8374272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of image-enhanced endoscopy into solo and group practices for dysplasia detection in Crohn's disease and ulcerative colitis.
    Leong RW; Butcher RO; Picco MF
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):419-25. PubMed ID: 24975532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory bowel disease cancer risk, detection and surveillance.
    Rogler G
    Dig Dis; 2012; 30 Suppl 2():48-54. PubMed ID: 23207932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer prevention in patients with inflammatory bowel disease.
    Itzkowitz SH
    Gastroenterol Clin North Am; 2002 Dec; 31(4):1133-44. PubMed ID: 12489282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoplasia yield and colonoscopic workload of surveillance regimes for colorectal cancer in colitis patients: a retrospective study comparing the performance of the updated AGA and BSG guidelines.
    Mooiweer E; van der Meulen AE; van Bodegraven AA; Jansen JM; Mahmmod N; Nijsten J; van Oijen MG; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2013 Nov; 19(12):2603-10. PubMed ID: 24030524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is there progress in preventive screening for colorectal carcinoma?].
    Müller A; Ammann R
    Schweiz Rundsch Med Prax; 1993 Apr; 82(16):472-4. PubMed ID: 8387686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenoma-like and non-adenoma-like dysplasia-associated lesion or mass in ulcerative colitis.
    Chen YX; Qiao L
    J Dig Dis; 2013 Apr; 14(4):157-9. PubMed ID: 23374421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to Laine et al.
    Higgins PD
    Am J Gastroenterol; 2015 Dec; 110(12):1735. PubMed ID: 26673506
    [No Abstract]   [Full Text] [Related]  

  • 31. Limits of diagnosis and molecular markers for early detection of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Katsumata D; Fujimori T
    Digestion; 2008; 77 Suppl 1():2-12. PubMed ID: 18204256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.
    Choi CH; Rutter MD; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Graham TA; Hart AL
    Am J Gastroenterol; 2015 Jul; 110(7):1022-34. PubMed ID: 25823771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of surveillance colonoscopy in long-standing ulcerative colitis.
    Koobatian GJ; Choi PM
    Am J Gastroenterol; 1994 Sep; 89(9):1472-5. PubMed ID: 8079922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to Editorial of Peter D.R. Higgins (July 2015).
    Laine L; Kaltenbach T; Barkun A; McQuaid KR; Subramanian V; Soetikno R
    Am J Gastroenterol; 2015 Dec; 110(12):1734-5. PubMed ID: 26673505
    [No Abstract]   [Full Text] [Related]  

  • 35. Colonoscopic surveillance for cancer in patients with chronic ulcerative colitis: is it working?
    Thirlby RC
    Gastroenterology; 1991 Feb; 100(2):570-2. PubMed ID: 1985056
    [No Abstract]   [Full Text] [Related]  

  • 36. What is the optimal strategy for colon cancer surveillance in patients with ulcerative colitis?
    Bauer WM; Lashner BA
    Cleve Clin J Med; 1999 May; 66(5):273, 277. PubMed ID: 10330779
    [No Abstract]   [Full Text] [Related]  

  • 37. To dye or not to dye? That is beyond question! Optimising surveillance colonoscopy is indispensable for detecting dysplasia in ulcerative colitis.
    Hata K; Watanabe T; Shinozaki M; Kojima T; Nagawa H
    Gut; 2004 Nov; 53(11):1722. PubMed ID: 15479703
    [No Abstract]   [Full Text] [Related]  

  • 38. Chromoendoscopy should be the standard method and more widely used for cancer surveillance colonoscopy in ulcerative colitis--con.
    Ullman TA
    Inflamm Bowel Dis; 2007 Oct; 13(10):1273-4; discussion 1275-6. PubMed ID: 17567865
    [No Abstract]   [Full Text] [Related]  

  • 39. [Colorectal cancer screening at Clínica Alemana, Santiago de Chile].
    Silva Mde L; Santander R; Gobelet J; Valdivieso E; Ramírez MA; Sáenz R; Alarcón G; Elías S; Olivares L
    Acta Gastroenterol Latinoam; 2011 Mar; 41(1):10-6. PubMed ID: 21539063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colonoscopic surveillance in ulcerative colitis--dysplasia through the looking glass.
    Fozard JB; Dixon MF
    Gut; 1989 Mar; 30(3):285-92. PubMed ID: 2651224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.